Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
Supporting Files
Public Domain
-
Aug 2005
-
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patients and postexposure prophylactic treatment of patients' close contacts.
-
Subjects:
-
Source:Emerg Infect Dis. 11(8):1280-1282.
-
Document Type:
-
Name as Subject:
-
Place as Subject:
-
Location:
-
Volume:11
-
Issue:8
-
Collection(s):
-
Main Document Checksum:urn:sha256:360ae3fbca79da862e359e3c80dac8ca931bf88fb59e4afcab17aeaaf4787d64
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases